CDH1 and cancer: Epithelial–mesenchymal transition (EMT) is a key process in CRC progression and metastasis, characterized by the loss of epithelial markers (e.g., E-cadherin) and the gain of mesenchymal markers (e.g., vimentin and ZEB1), enhancing cancer cell migration and invasion (18).